Media Coverage Report. Lasa Supergenerics Ltd. lists on NSE. Prepared by

Size: px

Start display at page:

Download "Media Coverage Report. Lasa Supergenerics Ltd. lists on NSE. Prepared by"

Curtis Austin
5 years ago
Views:

1 Media Coverage Report Lasa Supergenerics Ltd. lists on NSE Prepared by

2 INDEX Sr. No. Date Publication Edition Pg. No. Print 1 22-Sep-17 Financial Express Mumbai Sep-17 Afternoon Despatch & Courier Mumbai 25 Regionals 3 22-Sep-17 Janpath Samachar Siliguri Sep-17 Aadarsh Maharashtra Mumbai 04 Channels 5 21-Spe-17 ET Now National NA 6 21-Sep-17 CNBC Awaaz National NA 7 21-Sep-17 CNBC Bajar National NA Online 8 21-Sep-17 The Economic Times NA 9 21-Sep-17 Business Standard NA Sep-17 India Infoline NA Sep-17 Zeebiz NA Sep-17 Outlook India NA Sep-17 India Today NA Sep-17 India Today NA Sep-17 India.com NA Sep-17 Shafaqana NA Sep-17 Traders.com NA

3 Publication : Financial Express Edition : Mumbai Date : September 22, 2017 Page: 13

4 Publication : Afternoon Despatch & Courier Edition : Mumbai Date : September 22, 2017 Page: 25

5 Publication : Janpath Samachar Edition : Siliguri Date : September 22, 2017 Page: 11

6 Publication : Aadarsh Maharashtra Edition : Mumbai Date : September 22, 2017 Page: 04

7 Channel : ET Now Edition : Electronic Page: NA

8 Channel : CNBC Awaaz Edition : Electronic Page: NA

9 Channel : CNBC Bajar Edition : Electronic Page: NA

10 Publication : The Economic Times Link : tocks/news/lasa-supergenerics-lists-at-rs on-nse-omkar-speciality-drops- 5/articleshow/ cms Lasa Supergenerics lists at Rs on NSE; Omkar Speciality drops 5% NEW DELHI: Shares of Lasa Supergenerics got listed at Rs on NSE. The stock of the demerger entity of Omkar SpecialityBSE % later climbed 5 per cent to hit a high of Rs on the stock exchange. Shares of Omkar Speciality Chemicals, on the other hand, dropped 4.5 per cent to Rs 81.65, eventually closing at Rs 82.45, down 3.57 per cent. Every shareholder holding a single share of Omkar Speciality Chemicals has got one share of LASA Laboratories after the demerger. The record date was set at July 13 Omkar Speciality Chemicals, which has carried some investments in LASA Laboratories in the past, holds around 10 per cent of the equity of LASA Laboratories post the demerger. Omkar Speciality Chemicals is primarily engaged in the manufacture and sale of specialty chemicals and intermediates for chemical and allied industries.

11 Publication : Business Standard Link : _1.html Lasa Supergenerics lists on bourses The equity shares of Lasa Supergenerics Ltd, a demerged entity of Omkar Speciality Chemicals Ltd (OSCL) today got listed on the National Stock Exchange (NSE) and BSE. Lasa group is a veterinary API manufacturing entity, which was acquired in April 2012 as a 100 per cent subsidiary by OSCL. As per the scheme of arrangement, Lasa Supergenerics has made allotment of 2,05,78,004 equity shares of Rs 10 each to the shareholders of the OSCL in the ratio of 1 equity share of Rs 10 each of Lasa Supergenerics for every share of Rs 10 each held by the shareholders of Omkar Speciality Chemicals. "Going forward, we are looking at organic CAGR of per cent and forward integration into formulations business. The company posted a turnover of Rs 200 crore and aims to cross Rs 500 crore mark by 2020," Lasa Supergenerics chairman Omkar Herlekar told PTI here. The company is also looking at increasing its footprint and targets 50 per cent of exports at Rs 250 crore by 2020, he said.

12 Publication : India Infoline Link : Lasa Supergenerics breaches upper circuit, Omkar Speciality down Demerged entity of Omkar Speciality, Lasa Supergenerics got its shares listed on the NSE at Rs per share on September 21, Demerged entity of Omkar Speciality, Lasa Supergenerics got its shares listed on the NSE at Rs per share on September 21, Lasa Supergenerics surged by 5% on the NSE to hit a high of Rs per share on the stock exchange on Thursday. Lasa Supergenerics hit an intraday high of Rs per share and an intraday low of Rs 136 per share on NSE on Thursday. The stock also breached its upper circuit. The stock recorded a trade volume of 7,96,802 shares and a trade value of Rs 1, lakh on NSE during the Thursday s trade. Meanwhile the share price of Omkar Speciality Chemicals fell by 4.5% to Rs per share on the NSE during Thursday s trade. At 1132 hours, Omkar Speciality Chemicals was trading at Rs per share, lower by 2.29% on NSE on September 21, Post the demerger, every shareholder holding one share of Omkar Speciality Chemicals was allotted one share of Lasa Laboratories. Omkar Speciality Chemicals has around 10% of the equity of LASA Laboratories after demerger. Omkar Speciality Chemicals is primarily engaged in the manufacture and sale of Specialty chemicals and intermediates for chemical and allied industries.

13 Publication : Zee Business Link : Lasa Supergenerics lists on bourses The equity shares of Lasa Supergenerics Ltd, a demerged entity of Omkar Speciality Chemicals Ltd (OSCL) today got listed on the National Stock Exchange (NSE) and BSE. Lasa group is a veterinary API manufacturing entity, which was acquired in April 2012 as a 100 per cent subsidiary by OSCL. As per the scheme of arrangement, Lasa Supergenerics has made allotment of 2,05,78,004 equity shares of Rs 10 each to the shareholders of the OSCL in the ratio of 1 equity share of Rs 10 each of Lasa Supergenerics for every share of Rs 10 each held by the shareholders of Omkar Speciality Chemicals. "Going forward, we are looking at organic CAGR of per cent and forward integration into formulations business. The company posted a turnover of Rs 200 crore and aims to cross Rs 500 crore mark by 2020," Lasa Supergenerics chairman Omkar Herlekar told

14 Publication : Outlook India Link : Lasa Supergenerics lists on bourses Mumbai, Sep 21 The equity shares of Lasa Supergenerics Ltd, a demerged entity of Omkar Speciality Chemicals Ltd (OSCL) today got listed on the National Stock Exchange (NSE) and BSE. Lasa group is a veterinary API manufacturing entity, which was acquired in April 2012 as a 100 per cent subsidiary by OSCL. As per the scheme of arrangement, Lasa Supergenerics has made allotment of 2,05,78,004 equity shares of Rs 10 each to the shareholders of the OSCL in the ratio of 1 equity share of Rs 10 each of Lasa Supergenerics for every share of Rs 10 each held by the shareholders of Omkar Speciality Chemicals. "Going forward, we are looking at organic CAGR of per cent and forward integration into formulations business. The company posted a turnover of Rs 200 crore and aims to cross Rs 500 crore mark by 2020," Lasa Supergenerics chairman Omkar Herlekar told PTI here. The company is also looking at increasing its footprint and targets 50 per cent of exports at Rs 250 crore by 2020, he said.

15 Publication : India Today Link : Lasa Supergenerics lists on bourses Mumbai, Sep 21 (PTI) The equity shares of Lasa Supergenerics Ltd, a demerged entity of Omkar Speciality Chemicals Ltd (OSCL) today got listed on the National Stock Exchange (NSE) and BSE. Lasa group is a veterinary API manufacturing entity, which was acquired in April 2012 as a 100 per cent subsidiary by OSCL. As per the scheme of arrangement, Lasa Supergenerics has made allotment of 2,05,78,004 equity shares of Rs 10 each to the shareholders of the OSCL in the ratio of 1 equity share of Rs 10 each of Lasa Supergenerics for every share of Rs 10 each held by the shareholders of Omkar Speciality Chemicals. "Going forward, we are looking at organic CAGR of per cent and forward integration into formulations business. The company posted a turnover of Rs 200 crore and aims to cross Rs 500 crore mark by 2020," Lasa Supergenerics chairman Omkar Herlekar told PTI here. The company is also looking at increasing its footprint and targets 50 per cent of exports at Rs 250 crore by 2020, he said.

16 Publication : India Today Link : Lasa Supergenerics lists on bourses Mumbai, Sep 21 (PTI) The equity shares of Lasa Supergenerics Ltd, a demerged entity of Omkar Speciality Chemicals Ltd (OSCL) today got listed on the National Stock Exchange (NSE) and BSE. Lasa group is a veterinary API manufacturing entity, which was acquired in April 2012 as a 100 per cent subsidiary by OSCL. As per the scheme of arrangement, Lasa Supergenerics has made allotment of 2,05,78,004 equity shares of Rs 10 each to the shareholders of the OSCL in the ratio of 1 equity share of Rs 10 each of Lasa Supergenerics for every share of Rs 10 each held by the shareholders of Omkar Speciality Chemicals. "Going forward, we are looking at organic CAGR of per cent and forward integration into formulations business. The company posted a turnover of Rs 200 crore and aims to cross Rs 500 crore mark by 2020," Lasa Supergenerics chairman Omkar Herlekar told PTI here. The company is also looking at increasing its footprint and targets 50 per cent of exports at Rs 250 crore by 2020, he said.

17 Publication : India.com Link : Lasa Supergenerics lists on bourses Mumbai, Sep 21 (PTI) The equity shares of Lasa Supergenerics Ltd, a demerged entity of Omkar Speciality Chemicals Ltd (OSCL) today got listed on the National Stock Exchange (NSE) and BSE. Lasa group is a veterinary API manufacturing entity, which was acquired in April 2012 as a 100 per cent subsidiary by OSCL. As per the scheme of arrangement, Lasa Supergenerics has made allotment of 2,05,78,004 equity shares of Rs 10 each to the shareholders of the OSCL in the ratio of 1 equity share of Rs 10 each of Lasa Supergenerics for every share of Rs 10 each held by the shareholders of Omkar Speciality Chemicals. Going forward, we are looking at organic CAGR of per cent and forward integration into formulations business. The company posted a turnover of Rs 200 crore and aims to cross Rs 500 crore mark by 2020, Lasa Supergenerics chairman Omkar Herlekar told PTI here. The company is also looking at increasing its footprint and targets 50 per cent of exports at Rs 250 crore by 2020, he said.

18 Publication : Shafaqna Link : Lasa Supergenerics lists on bourses The equity shares of Lasa Supergenerics Ltd, a demerged entity of Omkar Speciality Chemicals Ltd (OSCL) today got listed on the National Stock Exchange (NSE) and BSE. Lasa group is a veterinary API manufacturing entity, which was acquired in April 2012

19 Publication : 4-Traders Link : SPECIALITY-CHEMICAL /news/Lasa- Supergenerics-breaches-upper-circuit-Omkar- Speciality-down / Lasa Supergenerics : breaches upper circuit, Omkar Speciality down Demerged entity of Omkar Speciality, Lasa Supergenerics got its shares listed on the NSE at Rs per share on September 21, Demerged entity of Omkar Speciality, Lasa Supergenerics got its shares listed on the NSE at Rs per share on September 21, Lasa Supergenerics surged by 5% on the NSE to hit a high of Rs per share on the stock exchange on Thursday. Lasa Supergenerics hit an intraday high of Rs per share and an intraday low of Rs 136 per share on NSE on Thursday. The stock also breached its upper circuit. The stock recorded a trade volume of 7,96,802 shares and a trade value of Rs 1, lakh on NSE during the Thursday s trade. Meanwhile the share price of Omkar Speciality Chemicals fell by 4.5% to Rs per share on the NSE during Thursday s trade. At 1132 hours, Omkar Speciality Chemicals was trading at Rs per share, lower by 2.29% on NSE on September 21, Post the demerger, every shareholder holding one share of Omkar Speciality Chemicals was allotted one share of Lasa Laboratories. Omkar Speciality Chemicals has around 10% of the equity of LASA Laboratories after demerger. Omkar Speciality Chemicals is primarily engaged in the manufacture and sale of Specialty chemicals and intermediates for chemical and allied industries.

COURT CONVENED MEETING OF THE SECURED CREDITORS OF OMKAR SPECIALITY CHEMICALS LIMITED

COURT CONVENED MEETING OF THE SECURED CREDITORS OF OMKAR SPECIALITY CHEMICALS LIMITED OMKAR SPECIALITY CHEMICALS LIMITED CIN: L24110MH2005PLC151589 Registered Office: B-34, M.I.D.C., Badlapur (East), Thane - 421503 Tel No.: +91-251-2697340/ 2690651, Fax No.: +91-251-2697347/ 2691572 Website: